erythromycin has been researched along with Disbacteriosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, PR; Brown, RG; MacIntyre, DA | 1 |
Bennett, PR; Brown, RG; Holmes, E; Kindinger, LM; Lee, YS; Lehne, B; MacIntyre, DA; Marchesi, JR; Nicholson, JK; Smith, A; Terzidou, V | 1 |
1 review(s) available for erythromycin and Disbacteriosis
Article | Year |
---|---|
Vaginal Microbiome in Preterm Rupture of Membranes.
Topics: Anti-Bacterial Agents; Chorioamnionitis; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Lactobacillus; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Risk Factors; Vagina | 2020 |
1 other study(ies) available for erythromycin and Disbacteriosis
Article | Year |
---|---|
Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.
Topics: Adult; Antibiotic Prophylaxis; Cohort Studies; Disease Progression; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Prenatal Care; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 16S; Vagina | 2018 |